Reso25 16295 - Laserfiche WebLink

Browse Search

4 future date. R&D/Laboratory use would be governed by Biosafety Levels, or BSLs. According to the Centers for Disease Control and Prevention (CDC), biosafety is the application of safety precautions that reduce a laboratory or lab worker’s risk of exposure to potentially infectious microbes and limit contamination of the work environment and community. There are four BSLs (BSL-1 through BSL-4). Each biosafety level builds on the controls of the level before it. BSL 1 presents the lowest risk of microbes, while BSL- 4 represents the highest. Future R&D/Laboratory use at 901 El Camino Real would be restricted to BSL-1 and BSL- 2. In addition, the R&D/Laboratory use would not be permitted on the first floor and would not be permitted on the second floor directly above the teen center/multi-purpose space in accordance with the DTPP requirements. The teen center/multi-purpose space would be accessed directly from the outside through separate entrances from the rest of the building. The teen center/multi-purpose space would be physically separated from the first floor lease space by a full height fire and smoke rated partition and from the second floor through fire rated concrete slab construction. The HVAC system proposed for the teen center/multi- purpose space would be a completely independent system from all others of the building. (Meyers+ Engineers, “901 El Camino Real Teen Center, High School and Life Science Program” memo, January 28, 2025) BSL-1 is a biosafety level designated for working with agents that don’t cause disease in healthy humans (for example, non-pathogenic E. coli) and present minimal potential hazard to laboratory personnel and the environment. BSL-1 represents a basic level of containment that relies on standard, microbiological best practices and procedures with no special primary or secondary barriers, other than a door, a sink for handwashing, and non-porous work surfaces that are cleanable and easy to decontaminate. Biosafety Level 2 (BSL-2) builds upon BSL-1. BSL-2 is suitable for work with agents associated with human disease (for example, the flu) and pose moderate hazards to personnel and the environment. BSL- 2 differs from BSL-1 primarily because: 1) laboratory personnel receive specific training in handling pathogenic agents and are supervised by scientists competent in handling infectious agents and associated procedures; 2) access to the laboratory is restricted when work is being conducted; and 3) all procedures in which infectious aerosols or splashes may be created are conducted in Biosafety cabinets (BSCs) or other physical containment equipment.1 If a R&D/Laboratory tenant is identified, then the Redwood City Community Development and Transportation Department, Fire Department, and all required external local, regional, state or federal agencies, shall review and approve or conditionally approve the related safety plans (including the Biosafety Plan, Evacuation Plan, and Medical Waste Management Plan) and compliance with this requirement shall be verified by the Planning Manager/Designee prior to issuance of building permit or Certificate of Occupancy per DTPP Section 2.2.4(E). Other proposed improvements include approximately 15,058 SF of private open space on the Level 7 terrace, an approximately 3,934 SF public open space plaza (“Chrysanthemum Plaza”), and approximately 10,151 SF of passive creek open space (Plan Sheet G2.01,8/5/24). To accommodate the Commercial Component, the applicant is requesting that the portion of California Street that runs through the property be vacated and incorporated into this component’s site. The City has declared this land to be exempt surplus under the Surplus Land Act and the California Department of Housing and Community Development (HCD) has approved this determination. Thus, California Street between James Avenue and Winklebleck Street would be eliminated from the City’s circulation network, and the 1 Biosafety in Microbiological and Biomedical Laboratories—6th Edition, Revised June 2020, https://www.cdc.gov/labs/pdf/SF__19_308133-A_BMBL6_00-BOOK-WEB-final-3.pdf ATTY/RESO.0028/CC RESO CEQA GUIDLINES (920 SHASTA) - EXHIBIT A REV: 04-22-25 VR Page 4 of 148